Side Effects of Chlorzoxazone
The most critical side effect of chlorzoxazone is potentially fatal hepatocellular toxicity, which occurs unpredictably and requires immediate discontinuation if any signs of liver injury develop. 1
Serious and Life-Threatening Side Effects
Hepatotoxicity (Most Critical)
- Fatal hepatocellular toxicity has been reported, though rare, with an idiosyncratic and unpredictable mechanism. 1
- Two deaths from hepatic failure have been documented in FDA records and medical literature since 1970. 2
- Discontinue chlorzoxazone immediately if patients develop fever, rash, anorexia, nausea, vomiting, fatigue, right upper quadrant pain, dark urine, jaundice, or abnormal liver enzymes (AST, ALT, alkaline phosphatase, bilirubin). 1
- Swedish adverse reaction data shows chlorzoxazone has a comparatively greater incidence of hepatotoxic reactions among commonly used muscle relaxants. 2
Central Nervous System Depression
- Chlorzoxazone causes CNS depression with sedation, drowsiness, dizziness, and light-headedness. 1
- Concomitant use with alcohol or other CNS depressants produces additive effects and significantly increases respiratory depression risk. 1
- Overdose can cause coma requiring intubation and mechanical ventilation. 3
- The drug may interact with benzodiazepine receptors, making flumazenil potentially useful in overdose reversal. 3
Common Side Effects
Gastrointestinal Effects
- Gastrointestinal bleeding has been rarely associated with chlorzoxazone. 1
- Nausea and vomiting may occur, particularly as early signs of hepatotoxicity. 1
Neurological Effects
- Drowsiness, dizziness, and light-headedness are commonly reported. 1
- Malaise or overstimulation may occur in occasional patients. 1
Dermatologic and Allergic Reactions
- Allergic-type skin rashes, petechiae, or ecchymoses may develop during treatment. 1
- Angioneurotic edema or anaphylactic reactions are extremely rare. 1
Other Effects
- Urine discoloration may occur from a phenolic metabolite of chlorzoxazone, which has no known clinical significance. 1
- Tachycardia and postural hypotension have been reported. 4
- Ataxia can occur, particularly concerning for fall risk. 4
Special Population Concerns
Older Adults
- The American Geriatrics Society identifies chlorzoxazone as potentially inappropriate for older adults due to high risk of anticholinergic effects, sedation, and CNS depression. 5, 6
- Older adults face significantly increased fall risk from CNS effects, which is particularly dangerous in diabetic patients already at 1.79 times higher hip fracture risk. 6
Pregnancy
- Safe use has not been established regarding possible adverse effects on fetal development. 1
- Use only when potential benefits outweigh possible risks in women of childbearing potential. 1
Chronic Use
- Chronic chlorzoxazone use is associated with hepatotoxicity, CNS depression, and abuse risk, and should be avoided for long-term therapy. 5
- Most clinical trials evaluating chlorzoxazone are short-term, with insufficient evidence supporting long-term efficacy. 5
Clinical Monitoring Recommendations
- Instruct patients to report early hepatotoxicity signs immediately: fever, rash, anorexia, nausea, vomiting, fatigue, right upper quadrant pain, dark urine, or jaundice. 1
- Monitor liver enzymes if hepatotoxicity is suspected. 1
- Assess fall risk at baseline and during treatment, especially in older adults and diabetic patients. 6
- Avoid combining with alcohol or other CNS depressants. 1
- There is no evidence that chlorzoxazone causes renal damage. 1